GlassScriptPhysician profile
Amy K Alderman
NPI 1730287509
$6,304.12
in general payments reported to CMS, 2019-2025
11 companies · $420 in 2025
The $420 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,930 · 2020: $797 · 2021: $698 · 2022: $1,349 · 2023: $812 · 2024: $298 · 2025: $420.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,530.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,530.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $3,619.52 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 4 Breast Tissue Expander |
| Merz North America, INC. | $1,943.49 | 2019-2023 | |
| Galderma Laboratories, L.P. | $374.29 | 2019-2025 | |
| Tepha INC | $170.85 | 2019 | |
| Allergan, INC. | $54.22 | 2019 | |
| Bard Peripheral Vascular, INC. | $46.39 | 2021 | |
| Davol INC. | $34.39 | 2022 | |
| Sientra, INC. | $25.11 | 2019 | |
| Medtronic, INC. | $18.44 | 2024 | Concertotm |
| Pacira Pharmaceuticals Incorporated | $17.42 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Alderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.